Overview

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and safety of Monosialoganglioside(GM1) to prevent the neurotoxicity induced by cisplatin
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborator:
Southern Medical University, China
Treatments:
Cisplatin